Valneva SE
INRLFOTCHealthcare● Active
$2.80
+$0.06(+2.19%)
Market Cap$531010698
P/E Ratio—
52W High$6.28
52W Low$2.46
Valneva SE (INRLF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
INRLF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 13, 2026EPS Actual
-$0.21
Est. -$0.07 · -184.7%
Revenue
$0.04B
Est. $0.05B · -33.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 13, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
INRLF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$78.12
Rev. $1025.0B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$78.12
Rev. Est.$1025.0B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.09 | — | — | — | $0.04B | — |
| ▼ Q2 FY2026 | May 13, 2026 | -$0.07 | -$0.21 | -184.7% | $0.04B | $0.05B | -33.5% |
| ▼ Q1 FY2026 | Mar 18, 2026 | -$0.18 | -$0.35 | -90.3% | $0.06B | $0.05B | +5.9% |
| ▼ Q4 FY2025 | Nov 20, 2025 | -$0.16 | -$0.34 | -105.2% | $0.03B | $0.05B | -29.9% |
| ▲ Q3 FY2025 | Aug 12, 2025 | -$0.16 | -$0.09 | +45.7% | $0.06B | $0.04B | +45.5% |
| ▲ Q2 FY2025 | May 7, 2025 | -$0.14 | -$0.07 | +51.5% | $0.05B | $0.04B | +21.3% |
| ▼ Q1 FY2025 | Mar 20, 2025 | -$0.09 | -$0.29 | -212.3% | $0.05B | $0.04B | +49.4% |
| ▲ Q4 FY2024 | Nov 7, 2024 | -$0.14 | -$0.08 | +43.3% | $0.05B | $0.05B | +0.4% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.09
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 13, 2026Miss
EPS Actual
-$0.21
EPS Est.
-$0.07
EPS Surpr.
-184.7%
Revenue
$0.04B
Q1 FY2026
Mar 18, 2026Miss
EPS Actual
-$0.35
EPS Est.
-$0.18
EPS Surpr.
-90.3%
Revenue
$0.06B
Q4 FY2025
Nov 20, 2025Miss
EPS Actual
-$0.34
EPS Est.
-$0.16
EPS Surpr.
-105.2%
Revenue
$0.03B
Q3 FY2025
Aug 12, 2025Beat
EPS Actual
-$0.09
EPS Est.
-$0.16
EPS Surpr.
+45.7%
Revenue
$0.06B
Q2 FY2025
May 7, 2025Beat
EPS Actual
-$0.07
EPS Est.
-$0.14
EPS Surpr.
+51.5%
Revenue
$0.05B
Q1 FY2025
Mar 20, 2025Miss
EPS Actual
-$0.29
EPS Est.
-$0.09
EPS Surpr.
-212.3%
Revenue
$0.05B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
-$0.08
EPS Est.
-$0.14
EPS Surpr.
+43.3%
Revenue
$0.05B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.04 | $-0.03 | $-0.03 | 1 |
| Q3 FY2026 | $-0.09 | $-0.08 | $-0.07 | 1 |
| Q2 FY2026 | $-0.09 | $-0.08 | $-0.08 | 1 |
| Q1 FY2026 | $-0.07 | $-0.06 | $-0.06 | 1 |
| Q4 FY2025 | $-0.17 | $-0.15 | $-0.14 | 1 |
| Q3 FY2025 | $-0.16 | $-0.14 | $-0.13 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 4 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 4 |
| Q1 FY2026 | $0.0B | $0.0B | $0.1B | 4 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 13, 2026 | -184.7% | $2.80 | $2.58 | -7.86% |
| ▼ Q1 FY2026 | Mar 18, 2026 | -90.3% | $5.10 | $5.10 | +0.00% |
| ▼ Q4 FY2025 | Nov 20, 2025 | -105.2% | $4.40 | $4.40 | +0.00% |
| ▲ Q3 FY2025 | Aug 12, 2025 | +45.7% | $4.25 | $4.25 | +0.00% |
| ▲ Q2 FY2025 | May 7, 2025 | +51.5% | $3.27 | $3.27 | +0.00% |
| ▼ Q1 FY2025 | Mar 20, 2025 | -212.3% | $3.16 | $3.16 | +0.00% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +43.3% | $2.83 | $2.74 | -3.18% |
| ▼ Q3 FY2024 | Aug 13, 2024 | -21.0% | $3.45 | $3.65 | +5.80% |
Q2 FY2026-7.86%
Report Date
May 13, 2026
EPS Beat/Miss
-184.7%
Price Before
$2.80
Price After
$2.58
Q1 FY2026+0.00%
Report Date
Mar 18, 2026
EPS Beat/Miss
-90.3%
Price Before
$5.10
Price After
$5.10
Q4 FY2025+0.00%
Report Date
Nov 20, 2025
EPS Beat/Miss
-105.2%
Price Before
$4.40
Price After
$4.40
Q3 FY2025+0.00%
Report Date
Aug 12, 2025
EPS Beat/Miss
+45.7%
Price Before
$4.25
Price After
$4.25
Q2 FY2025+0.00%
Report Date
May 7, 2025
EPS Beat/Miss
+51.5%
Price Before
$3.27
Price After
$3.27
Q1 FY2025+0.00%
Report Date
Mar 20, 2025
EPS Beat/Miss
-212.3%
Price Before
$3.16
Price After
$3.16
Q4 FY2024-3.18%
Report Date
Nov 7, 2024
EPS Beat/Miss
+43.3%
Price Before
$2.83
Price After
$2.74
Q3 FY2024+5.80%
Report Date
Aug 13, 2024
EPS Beat/Miss
-21.0%
Price Before
$3.45
Price After
$3.65
Avg Beat Reaction-1.06%
Avg Miss Reaction-0.41%
Beat Rate3 / 8 quarters
Largest Move-7.86% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: INRLF ends December
Valneva SE (INRLF) most recently reported earnings on May 13, 2026 for Q2 FY2026, posting EPS of $-0.21 — missing the analyst consensus of $-0.07 by -184.7%. The next INRLF earnings date is expected around September 1, 2026.
Each quarter, investors track INRLF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. INRLF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
INRLF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
INRLF earnings · 5 questionsValneva SE's next earnings report is expected around September 1, 2026. INRLF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; INRLF historically reports after market close (AMC).
INRLF earnings datewhen is INRLF earningsINRLF next earnings datewhen does INRLF report earningsINRLF earnings calendar
▸ Source: FMP · Valneva SE SEC filings · US GAAP · Valneva SE SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026